Q/C Technologies, Inc. Net Income (Loss) Available to Common Stockholders, Basic
Q/C Technologies, Inc. (QCLS) reported Net Income (Loss) Available to Common Stockholders, Basic of -$6.54 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2026-08-12
- Q/C Technologies, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2026-06-30 was -$6.54M.
- Q/C Technologies, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2026-03-31 was -$1.53M.
- Q/C Technologies, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2025-12-31 was -$6.56M.
- Q/C Technologies, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2025-09-30 was -$3.71M.
- Q/C Technologies, Inc. net income (loss) available to common stockholders, basic for fiscal 2025 was -$14.98M.
- Q/C Technologies, Inc. net income (loss) available to common stockholders, basic for fiscal 2024 was -$27.16M.
- Q/C Technologies, Inc. net income (loss) available to common stockholders, basic for fiscal 2023 was -$8.22M.
- Q/C Technologies, Inc. net income (loss) available to common stockholders, basic for fiscal 2022 was -$15.20M.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 3 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 6 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$6.54M 10-Q · filed 2026-08-12 | -$8.07M 10-Q · filed 2026-08-12 | -$14.63M derived: sum of 3 quarters · filed 2026-08-12 | -$18.34M derived: sum of 4 quarters · filed 2026-08-12 | |||
| 2026-03-31 | -$1.53M 10-Q · filed 2026-05-15 | -$8.09M derived: sum of 2 quarters · filed 2026-05-15 | -$11.80M derived: sum of 3 quarters · filed 2026-05-15 | -$14.57M derived: sum of 4 quarters · filed 2026-08-12 | |||
| 2025-12-31 | -$6.56M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | -$10.27M derived: sum of 2 quarters · filed 2026-04-15 | -$13.05M derived: sum of 3 quarters · filed 2026-08-12 | -$14.98M 10-K · filed 2026-04-15 | |||
| 2025-09-30 | -$3.71M 10-Q · filed 2025-11-19 | -$6.49M derived: sum of 2 quarters · filed 2026-08-12 | -$8.42M 10-Q · filed 2025-11-19 | -$11.56M derived: sum of 4 quarters · filed 2026-08-12 | |||
| 2025-06-30 | -$2.77M 10-Q · filed 2026-08-12 | -$4.71M 10-Q · filed 2026-08-12 | -$7.85M derived: sum of 3 quarters · filed 2026-08-12 | -$10.53M derived: sum of 4 quarters · filed 2026-08-12 | |||
| 2025-03-31 | -$1.94M 10-Q · filed 2026-05-15 | -$5.07M derived: sum of 2 quarters · filed 2026-05-15 | -$7.75M derived: sum of 3 quarters · filed 2026-05-15 | -$18.10M derived: sum of 4 quarters · filed 2026-05-15 | |||
| 2024-12-31 | -$3.14M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | -$5.82M derived: sum of 2 quarters · filed 2026-04-15 | -$16.16M derived: sum of 3 quarters · filed 2026-04-15 | -$27.16M 10-K · filed 2026-04-15 | |||
| 2024-09-30 | -$2.68M 10-Q · filed 2025-11-19 | -$13.02M derived: sum of 2 quarters · filed 2025-11-19 | -$24.03M 10-Q · filed 2025-11-19 | -$28.92M derived: sum of 4 quarters · filed 2025-11-19 | |||
| 2024-06-30 | -$10.34M 10-Q · filed 2025-08-19 | -$21.34M 10-Q · filed 2025-08-19 | -$26.24M derived: sum of 3 quarters · filed 2025-08-19 | -$23.35M derived: sum of 4 quarters · filed 2025-08-19 | |||
| 2024-03-31 | -$11.00M 10-Q · filed 2025-05-15 | -$15.89M derived: sum of 2 quarters · filed 2025-05-15 | -$13.01M derived: sum of 3 quarters · filed 2025-05-15 | -$17.55M derived: sum of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | -$4.89M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-11 | -$2.01M derived: sum of 2 quarters · filed 2025-04-11 | -$6.55M derived: sum of 3 quarters · filed 2025-04-11 | -$8.22M 10-K · filed 2025-04-11 | |||
| 2023-09-30 | $2.88M 10-Q · filed 2024-11-14 | -$1.66M derived: sum of 2 quarters · filed 2024-11-14 | -$3.33M 10-Q · filed 2024-11-14 | -$7.07M derived: sum of 4 quarters · filed 2024-11-14 | |||
| 2023-06-30 | -$4.54M 10-Q · filed 2024-08-19 | -$6.21M 10-Q · filed 2024-08-19 | -$9.96M derived: sum of 3 quarters · filed 2024-08-19 | -$13.65M derived: sum of 4 quarters · filed 2024-08-19 | |||
| 2023-03-31 | -$1.67M 10-Q · filed 2024-05-15 | -$5.42M derived: sum of 2 quarters · filed 2024-05-15 | -$9.11M derived: sum of 3 quarters · filed 2024-05-15 | -$12.75M derived: sum of 4 quarters · filed 2024-05-15 | |||
| 2022-12-31 | -$3.75M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$7.44M derived: sum of 2 quarters · filed 2024-04-01 | -$11.08M derived: sum of 3 quarters · filed 2024-04-01 | -$15.20M 10-K · filed 2024-04-01 | |||
| 2022-09-30 | -$3.69M 10-Q · filed 2023-11-14 | -$7.33M derived: sum of 2 quarters · filed 2023-11-14 | -$11.45M 10-Q · filed 2023-11-14 | ||||
| 2022-06-30 | -$3.64M 10-Q · filed 2023-08-14 | -$7.76M 10-Q · filed 2023-08-14 | |||||
| 2022-03-31 | -$4.12M 10-Q · filed 2023-05-15 | ||||||
| 2020-06-30 | $3.63M 10-Q · filed 2020-08-14 | $7.17M 10-Q · filed 2020-08-14 | |||||
| 2020-03-31 | $3.54M 10-Q · filed 2020-05-15 | ||||||
| 2019-09-30 | $837.03K 10-Q · filed 2019-11-14 | $1.63M derived: sum of 2 quarters · filed 2020-08-14 | $2.55M 10-Q · filed 2019-11-14 | $6.39M derived: sum of 4 quarters · filed 2020-08-14 | |||
| 2019-06-30 | $794.89K 10-Q · filed 2020-08-14 | $1.71M 10-Q · filed 2020-08-14 | $5.55M derived: sum of 3 quarters · filed 2020-08-14 | $8.63M derived: sum of 4 quarters · filed 2020-08-14 | |||
| 2019-03-31 | $916.96K 10-Q · filed 2020-05-15 | $4.75M derived: sum of 2 quarters · filed 2020-05-15 | $7.84M derived: sum of 3 quarters · filed 2020-05-15 | $9.91M derived: sum of 4 quarters · filed 2020-05-15 | |||
| 2018-12-31 | $3.84M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $6.92M derived: sum of 2 quarters · filed 2019-11-14 | $8.99M derived: sum of 3 quarters · filed 2019-11-14 | $10.85M 10-K · filed 2019-04-01 | |||
| 2018-09-30 | $3.08M 10-Q · filed 2019-11-14 | $3.08M 10-Q · filed 2018-11-14 | $5.15M derived: sum of 2 quarters · filed 2019-11-14 | $7.01M 10-Q · filed 2019-11-14 | $11.03M derived: sum of 4 quarters · filed 2019-11-14 | ||
| 2018-06-30 | $2.07M 10-Q · filed 2019-08-14 | $3.93M 10-Q · filed 2019-08-14 | $7.95M derived: sum of 3 quarters · filed 2019-08-14 | $9.13M derived: sum of 4 quarters · filed 2019-08-14 | |||
| 2018-03-31 | $1.86M 10-Q · filed 2019-05-20 | $5.88M derived: sum of 2 quarters · filed 2019-05-20 | $7.06M derived: sum of 3 quarters · filed 2019-05-20 | $7.88M derived: sum of 4 quarters · filed 2019-05-20 | |||
| 2017-12-31 | $4.02M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $5.20M derived: sum of 2 quarters · filed 2019-04-01 | $6.02M derived: sum of 3 quarters · filed 2019-04-01 | $7.37M 10-K · filed 2019-04-01 | $5.81M 10-K · filed 2018-04-03 | ||
| 2017-09-30 | $1.18M 10-Q · filed 2018-11-14 | $2.00M derived: sum of 2 quarters · filed 2018-11-14 | $3.34M 10-Q · filed 2018-11-14 | ||||
| 2017-06-30 | $818.01K 10-Q · filed 2018-08-14 | $2.17M 10-Q · filed 2018-08-14 | $2.02M 10-Q · filed 2017-08-14 | ||||
| 2017-03-31 | $1.35M 10-Q · filed 2018-07-13 | ||||||
| 2016-12-31 | $3.30M 10-K/A · filed 2018-07-13 | ||||||
| 2016-06-30 | $1.01M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2018-07-13 | $2.52M 10-Q/A · filed 2018-07-13 | |||||
| 2016-03-31 | $1.51M 10-Q · filed 2017-05-15 | ||||||
| 2015-12-31 | $9.31M 10-K · filed 2017-04-11 | ||||||
| 2014-12-31 | $5.37M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $4.25M derived: sum of 2 quarters · filed 2016-03-30 | $3.74M derived: sum of 3 quarters · filed 2016-03-30 | $3.14M 10-K · filed 2016-03-30 | -$3.14M 10-K · filed 2015-03-23 | ||
| 2014-09-30 | -$1.12M 10-Q · filed 2014-11-13 | -$1.64M derived: sum of 2 quarters · filed 2014-11-13 | -$2.23M 10-Q · filed 2014-11-13 | ||||
| 2014-06-30 | -$510.79K 10-Q · filed 2014-08-12 | -$1.11M 10-Q · filed 2014-08-12 | |||||
| 2013-12-31 | -$781.56K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-23 | -$1.33M derived: sum of 2 quarters · filed 2015-03-23 | -$1.59M derived: sum of 3 quarters · filed 2015-03-23 | -$1.53M 10-K · filed 2015-03-23 | |||
| 2013-09-30 | -$544.37K 10-Q · filed 2014-11-13 | -$805.58K derived: sum of 2 quarters · filed 2014-11-13 | -$745.22K 10-Q · filed 2014-11-13 | ||||
| 2013-06-30 | -$261.21K 10-Q · filed 2014-08-12 | -$200.96K 10-Q · filed 2014-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |